Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Parisi

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Nucleic Acids Research|February 7, 2012
Picking ChIP-seq peak detectors for analyzing chromatin modification experimentsMariann Micsinai, Fabio Parisi, Francesco Strino, et al.
Journal of Clinical Medicine|November 27, 2025
Treatable Traits in Pediatric Interstitial Lung Diseases: Bridging the Gap to Tailored TherapeuticsGiuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Nucleic Acids Research|July 23, 2013
Arpeggio: harmonic compression of ChIP-seq data reveals protein-chromatin interaction signaturesKelly Patrick Stanton, Fabio Parisi, Francesco Strino, et al.
Frontiers in Pediatrics|December 31, 2020
COVID-19 Pneumonia in Children: From Etiology to ManagementGiuseppe Fabio Parisi, Cristiana Indolfi, Fabio Decimo, et al.
Viruses|September 28, 2023
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-PandemicSantiago Presti, Sara Manti, Francesco Gambilonghi, et al.
Children (Basel, Switzerland)|November 24, 2022
Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming ClearerSantiago Presti, Giuseppe Fabio Parisi, Maria Papale, et al.
Immunity, Inflammation and Disease|January 12, 2021
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature reviewSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Elife|July 3, 2014
Interactions with RNA direct the Polycomb group protein SCML2 to chromatin where it represses target genesRoberto Bonasio, Emilio Lecona, Varun Narendra, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
Type 2 inflammation in cystic fibrosis: New insightsSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Nucleic Acids Research|February 7, 2012
Picking ChIP-seq peak detectors for analyzing chromatin modification experimentsMariann Micsinai, Fabio Parisi, Francesco Strino, et al.
Journal of Clinical Medicine|November 27, 2025
Treatable Traits in Pediatric Interstitial Lung Diseases: Bridging the Gap to Tailored TherapeuticsGiuseppe Fabio Parisi, Maria Papale, Giulia Pecora, et al.
Nucleic Acids Research|July 23, 2013
Arpeggio: harmonic compression of ChIP-seq data reveals protein-chromatin interaction signaturesKelly Patrick Stanton, Fabio Parisi, Francesco Strino, et al.
Frontiers in Pediatrics|December 31, 2020
COVID-19 Pneumonia in Children: From Etiology to ManagementGiuseppe Fabio Parisi, Cristiana Indolfi, Fabio Decimo, et al.
Viruses|September 28, 2023
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-PandemicSantiago Presti, Sara Manti, Francesco Gambilonghi, et al.
Children (Basel, Switzerland)|November 24, 2022
Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming ClearerSantiago Presti, Giuseppe Fabio Parisi, Maria Papale, et al.
Immunity, Inflammation and Disease|January 12, 2021
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature reviewSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Elife|July 3, 2014
Interactions with RNA direct the Polycomb group protein SCML2 to chromatin where it represses target genesRoberto Bonasio, Emilio Lecona, Varun Narendra, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 26, 2022
Type 2 inflammation in cystic fibrosis: New insightsSara Manti, Giuseppe Fabio Parisi, Maria Papale, et al.
Pageof 11